SEC Filings

SEC Filings

Filing date	Description	Form	View
May 08, 2015	Statement of changes in beneficial ownership of securities	4	View HTML 0001209191-15-040635.pdf 0001209191-15-040635.rtf
May 08, 2015	Quarterly report which provides a continuing view of a company's financial position	10-Q	View HTML 0001193125-15-179571.pdf 0001193125-15-179571.rtf 0001193125-15-179571.xls EX-101.INS - XBRL INSTANCE DOCUMENT
May 08, 2015	Statement of changes in beneficial ownership of securities	4	View HTML 0001209191-15-040640.pdf 0001209191-15-040640.rtf
Apr 30, 2015	Report of unscheduled material events or corporate event	8-K	View HTML 0001193125-15-158850.pdf 0001193125-15-158850.rtf 0001193125-15-158850.xls
Apr 08, 2015	Report of unscheduled material events or corporate event	8-K	View HTML 0001193125-15-122943.pdf 0001193125-15-122943.rtf 0001193125-15-122943.xls
Apr 01, 2015	Official notification to shareholders of matters to be brought to a vote ("Proxy")	DEF 14A	View HTML 0001193125-15-116057.pdf 0001193125-15-116057.rtf 0001193125-15-116057.xls
Mar 13, 2015	Report of unscheduled material events or corporate event	8-K	View HTML 0001193125-15-091463.pdf 0001193125-15-091463.rtf 0001193125-15-091463.xls
Mar 13, 2015	Annual report which provides a comprehensive overview of the company for the past year	10-K	View HTML 0001193125-15-091468.pdf 0001193125-15-091468.rtf 0001193125-15-091468.xls EX-101.INS - XBRL INSTANCE DOCUMENT
Mar 11, 2015	Statement of changes in beneficial ownership of securities	4	View HTML 0001209191-15-025247.pdf 0001209191-15-025247.rtf
Mar 11, 2015	Annual filing director officer or owner of more than ten percent.	5	View HTML 0001209191-15-025244.pdf 0001209191-15-025244.rtf

Data provided by Kaleidoscope.

For investor inquiries, please contact:

ReShape Lifesciences Investor Contact:
Thomas Stankovich
Chief Financial Officer
949-276-6042
ir@ReShapeLifesci.com

Investor Contacts:
Rx Communications Group
Michael Miller
917-633-6086
mmiller@rxir.com

PRINT PAGE

EMAIL PAGE